发明名称 ARYL LACTAM KINASE INHIBITORS
摘要 The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
申请公布号 US2016152621(A1) 申请公布日期 2016.06.02
申请号 US201414902868 申请日期 2014.07.01
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 Hartz Richard A.;Ahuja Vijay T.;Bronson Joanne J.;Dzierba Carolyn Diane;Macor John E.;Nara Susheel Jethanand;Rajamani Ramkumar
分类号 C07D487/04;C07D413/12;C07D409/10;C07D249/06;C07D213/56;C07D277/30;C07D237/08;C07D285/12;C07D231/12;C07D233/61;C07D249/08;C07D213/65;C07D213/73;C07D417/12;C07D401/10;C07D401/12;C07D263/32 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein: R1 is selected from C1-C3alkoxy, C1-C3alkyl, cyano, diC1-C3alkylamino, halo, haloC1-C3alkoxy, haloC1-C3alkyl, hydroxy, and thienyl;R2 is selected from wherein Ra is selected from hydrogen, C1-C3alkoxy, C1-C3alkylamino, C1-C3alkylcarbonylamino, amino, and halo;R3 is selected from hydrogen and C1-C3alkyl;X is selected from hydrogen, C1-C3alkoxy, C1-C3alkyl, cyano, halo, haloC1-C3alkyl, Y is selected from hydrogen and halo;Z is selected from whereinn is 1 or 2;R4 is selected from C2-C6alkyl, C3-C6cycloalkyl, (C3-C6cycloalkyl)C1-C3alkyl, C1-3alkylthioC1-3alkyl, hydroxyC1-C6alkyl, and haloC1-C6alkyl;R5 and R6 are independently selected from hydrogen, C1-C3alkyl, C1-C3alkylsulfonyl, C3-C6cycloalkyl optionally substituted with an amino group, heterocyclyl, heterocyclylC1-C3alkyl, phenylC1-C3alkyl, phenylC1-C3alkylsulfonyl, and phenylsulfonyl; wherein the heterocyclyl, the heterocyclyl part of the heterocyclylC1-C3alkyl, and the phenyl part of the phenylC1-C3alkyl, phenylC1-C3alkylsulfonyl, and the phenylsulfonyl are optionally substituted with one group selected from C1-C3alkyl, halo, hydroxy; orR5 and R6, together with the nitrogen atom to which they are attached, form a five- or six-membered heterocyclic ring optionally containing a second nitrogen atom and optionally substituted with an amino group;Rb is selected from hydrogen, C1-C3alkoxy, C1-C3alkyl, halo, and halo C1alkyl;Rp is selected from hydrogen and C1-C3alkyl;Rq is selected from hydrogen and oxo; andRz is selected from hydrogen, C1-C3alkyl, and C1-C3alkylcarbonyl; or a pharmaceutically acceptable salt thereof.
地址 Princeton NJ US